Trials in San Antonio, Texas
Here are the top 10 medical studies for prostate cancer in San Antonio, Texas
Popular Filters
Phase 3 Trials
Cancer Imaging Agent
Copper PET Imaging for Recurrent Prostate Cancer
Recruiting2 awardsPhase 3
San Antonio, Texas
This trial is testing a new imaging technique using a radioactive substance called copper Cu 64 PSMA I&T injection to detect recurrent prostate cancer in patients who have previously undergone surgery or radiation therapy for prostate cancer
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
San Antonio, Texas
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
Androgen Receptor Inhibitor
Apalutamide + Hormone Therapy for Prostate Cancer
Recruiting1 awardPhase 3
San Antonio, Texas
This trial tests whether combining apalutamide with another treatment helps men with high-risk prostate cancer undergoing radiation therapy. The treatment aims to block and reduce male hormones that fuel cancer growth, potentially preventing the cancer from spreading. Apalutamide has been developed for treating prostate cancer and has shown effectiveness.
Trials With No Placebo
Cancer Imaging Agent
Copper PET Imaging for Recurrent Prostate Cancer
Recruiting2 awardsPhase 3
San Antonio, Texas
This trial is testing a new imaging technique using a radioactive substance called copper Cu 64 PSMA I&T injection to detect recurrent prostate cancer in patients who have previously undergone surgery or radiation therapy for prostate cancer
Hormone Therapy
BMS-986460 for Prostate Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
This trial is testing a new drug called BMS-986460 to see if it is safe and effective for men with advanced prostate cancer that doesn't respond to hormone treatments. The goal is to find out if the drug can help control the cancer's growth and spread.
XL092 + Immuno-Oncology Agents for Solid Tumors
Recruiting1 awardPhase 1
Austin, Texas
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Radioisotope Therapy
177Lu-PSMA-617 + Standard Therapy for Prostate Cancer
Recruiting2 awardsPhase 3
San Antonio, Texas
This trial tests if adding a radioactive drug to standard hormone treatments can better treat men with advanced prostate cancer. The drug targets and kills cancer cells with radiation, while standard treatments block hormones that help cancer grow.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.